Search

everythinglearnresearchcommunity

for

Search:↓

Diagnosing osteoporosis in transgender people is challenging due to unclear guidelines and hormone treatment effects.

Patients treated with long-term intralesional corticosteroids for alopecia areata should be monitored for bone density changes and advised on osteoporosis prevention.

Strontium ranelate is no longer available for treatment.

Denosumab treatment for osteoporosis can cause hair loss.

Ishige sinicola extract helps bone-building cells grow and mature, which could aid in treating osteoporosis.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

A woman with anorexia and Cushing's syndrome improved after tumor removal, highlighting the need to consider hormonal issues in psychiatric conditions.

The book is a valuable reference on androgenic disorders for professionals but not suitable for laypeople or medical students.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

Older patients with Cushing's syndrome often have different symptoms and treatment outcomes compared to younger patients.

miR-29 is a key factor that accelerates aging.

The document suggests using natural remedies like bloodletting and honey for various health issues but lacks scientific evidence for their effectiveness.

The document provides a comprehensive index of medical and surgical topics, including hair removal, hair restoration, and various treatments for injuries and conditions.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Women with early-onset baldness should be checked for early bone loss, but bone density doesn't change with baldness severity.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

Vitamin D is crucial for bone health and preventing serious diseases.

PRP may help with aging and osteoarthritis, improving tissue repair and reducing surgery risk.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.

Adequate steroid treatment needed to limit bone loss in PMR patients.

Rosella C. believes an earlier diagnosis of Cushing disease could have prevented severe symptoms.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.